TSS
TBIO

Two Sigma Securities’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Two Sigma Securities’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-584
Closed -$32.6K – 3482
2023
Q1 		$32.6K Buy
+584
New +$20.7K ﹤0.01% 2310

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's TBIO Position: Q2 2023 in Review

Two Sigma Securities sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2023, closing a stake of 584 shares — an estimated $32.6K sold.

Two Sigma Securities first reported a position in TBIO in Q1 2023 and held it in 1 quarter. The position peaked at $32.6K in Q1 2023. 29 funds tracked by Wall St. Rank hold TBIO as of Q2 2023.

  • Two Sigma Securities reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Securities sold 584 Telesis Bio, Inc. Common Stock shares in Q2 2023, an estimated $32.6K.
  • Two Sigma Securities first reported a position in Telesis Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Two Sigma Securities's Telesis Bio, Inc. Common Stock position peaked at $32.6K in Q1 2023.
  • 29 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.